Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran
about
Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Differential benefit risk asse ...... oembolism: focus on dabigatran
@ast
Differential benefit risk asse ...... oembolism: focus on dabigatran
@en
Differential benefit risk asse ...... oembolism: focus on dabigatran
@nl
type
label
Differential benefit risk asse ...... oembolism: focus on dabigatran
@ast
Differential benefit risk asse ...... oembolism: focus on dabigatran
@en
Differential benefit risk asse ...... oembolism: focus on dabigatran
@nl
prefLabel
Differential benefit risk asse ...... oembolism: focus on dabigatran
@ast
Differential benefit risk asse ...... oembolism: focus on dabigatran
@en
Differential benefit risk asse ...... oembolism: focus on dabigatran
@nl
P2860
P921
P356
P1476
Differential benefit risk asse ...... oembolism: focus on dabigatran
@en
P2093
Ernest H Law
Timothy S Leung
P2860
P304
P356
10.2147/DDDT.S70299
P407
P5008
P577
2015-07-09T00:00:00Z